[HTML][HTML] Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
C Ovadia, J Sajous, PT Seed, K Patel… - The lancet …, 2021 - thelancet.com
Background Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of
pregnancy, yet its largest trial detected minimal benefit for a composite outcome (stillbirth …
pregnancy, yet its largest trial detected minimal benefit for a composite outcome (stillbirth …
[HTML][HTML] Metformin versus insulin for the treatment of gestational diabetes
JA Rowan, WM Hague, W Gao… - New England Journal …, 2008 - Mass Medical Soc
Background Metformin is a logical treatment for women with gestational diabetes mellitus,
but randomized trials to assess the efficacy and safety of its use for this condition are lacking …
but randomized trials to assess the efficacy and safety of its use for this condition are lacking …
Calcium Supplementation In Nulliparous Women For The Prevention Of Pregnancy‐Induced Hypertension, Preeclampsia And Preterm Birth: An Australian …
CA Crowther, JE Hiller, B Pridmore… - Australian and New …, 1999 - Wiley Online Library
A multicentre, randomized controlled double‐blind trial in 5 maternity hospitals in Australia
assessed the effect of a daily supplement of calcium (1.8 g oral calcium or an oral placebo) …
assessed the effect of a daily supplement of calcium (1.8 g oral calcium or an oral placebo) …
Pharmacological interventions for treating intrahepatic cholestasis of pregnancy
KF Walker, LC Chappell, WM Hague… - Cochrane Database …, 2020 - cochranelibrary.com
Background Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that can develop
in pregnancy. It occurs when there is a build‐up of bile acids in the maternal blood. It has …
in pregnancy. It occurs when there is a build‐up of bile acids in the maternal blood. It has …
Treatment of gestational diabetes mellitus diagnosed early in pregnancy
D Simmons, J Immanuel, WM Hague… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether treatment of gestational diabetes before 20 weeks' gestation improves
maternal and infant health is unclear. Methods We randomly assigned, in a 1: 1 ratio …
maternal and infant health is unclear. Methods We randomly assigned, in a 1: 1 ratio …
[HTML][HTML] Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data …
C Ovadia, PT Seed, A Sklavounos, V Geenes, C Di Ilio… - The Lancet, 2019 - thelancet.com
Background Intrahepatic cholestasis of pregnancy is associated with adverse perinatal
outcomes, but the association with the concentration of specific biochemical markers is …
outcomes, but the association with the concentration of specific biochemical markers is …
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU) body composition at 2 years of age
JA Rowan, EC Rush, V Obolonkin, M Battin… - Diabetes …, 2011 - Am Diabetes Assoc
OBJECTIVE In women with gestational diabetes mellitus, who were randomized to
metformin or insulin treatment, pregnancy outcomes were similar (Metformin in Gestational …
metformin or insulin treatment, pregnancy outcomes were similar (Metformin in Gestational …
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational …
Background Thrombophilias are common disorders that increase the risk of pregnancy-
associated venous thromboembolism and pregnancy loss and can also increase the risk of …
associated venous thromboembolism and pregnancy loss and can also increase the risk of …
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
Objective To compare body composition and metabolic outcomes at 7–9 years in offspring of
women with gestational diabetes (GDM) randomized to metformin (±insulin) or insulin …
women with gestational diabetes (GDM) randomized to metformin (±insulin) or insulin …
The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives
WM Hague, J Adams, C Rodda, CG Brook… - Clinical …, 1990 - Wiley Online Library
Seventy‐seven female patients (36 adults and 41 children aged under 16 years) with
congenital adrenal hyperplasia (CAH) were assessed using pelvic ultrasound, as well as …
congenital adrenal hyperplasia (CAH) were assessed using pelvic ultrasound, as well as …